Sanofi
MODIFICATION OF ENGINEERED INFLUENZA HEMAGGLUTININ POLYPEPTIDES

Abstract:

The present invention provides, among other things, modified recombinant HA polypeptides with broadened immunogenic profile that extends coverage to antigenically distinct influenza strains and methods of making and using the same.